Displaying all 5 publications

Abstract:
Sort:
  1. Kamaludin F
    Nihon Rai Gakkai Zasshi, 1990 7 1;59(3-4):169-82.
    PMID: 2133468
    Matched MeSH terms: Leprostatic Agents/therapeutic use*
  2. Baharuddin H, Taib T, Zain MM, Ch'ng S
    Int J Rheum Dis, 2016 Oct;19(10):1035-1038.
    PMID: 27456320 DOI: 10.1111/1756-185X.12916
    Leprosy is a chronic granulomatous infection caused by Mycobacterium leprae with predominant involvement of skin and nerves. We present a 70-year-old man with leprosy whose initial presentation resembled rheumatologic disease, due to leprae reaction. He presented with an 8-week history of worsening neuropathic pain in the right forearm, associated with necrotic skin lesions on his fingers that had ulcerated. Physical examination revealed two tender necrotic ulcers at the tip of the right middle finger and the dorsal aspect of the left middle finger. The patient had right wrist tenosynovitis and right elbow bursitis. Apart from raised inflammatory markers, the investigations for infection, connective tissue disease, vasculitis, thromboembolic disease and malignancy were negative. During the fourth week of hospitalization, we noticed a 2-cm hypoesthetic indurated plaque on the right inner arm. Further examination revealed thickened bilateral ulnar, radial and popliteal nerves. A slit skin smear was negative. Two skin biopsies and a biopsy of the olecranon bursa revealed granulomatous inflammation. He was diagnosed with paucibacillary leprosy with neuritis. He responded well to multidrug therapy and prednisolone; his symptoms resolved over a few weeks. This case illustrates the challenges in diagnosing a case of leprosy with atypical presentation in a non-endemic country.
    Matched MeSH terms: Leprostatic Agents/therapeutic use
  3. Jamil A, Noor NM, Osman AS, Baseri MM, Muthupalaniappen L
    Indian J Dermatol Venereol Leprol, 2013 Jul-Aug;79(4):527-9.
    PMID: 23760326 DOI: 10.4103/0378-6323.113096
    Matched MeSH terms: Leprostatic Agents/therapeutic use*
  4. Jayalakshmi P
    Malays J Pathol, 1994 Jun;16(1):7-9.
    PMID: 16329568
    Leprosy is a chronic infectious disease and is still a public health problem in Malaysia. In 1926, the Leper Enactment Act was established which required compulsory notification and isolation of leprosy patients. As a result, the National Leprosy Control Centre (NLCC) was built in Sungai Buloh, Selangor. In 1969, the National Leprosy Control programme was launched with the objective of early case finding and decentralisation of treatment of leprosy. The treatment of leprosy patients is integrated with basic Medical and Health services in Malaysia. With the implementation of multiple drug therapy in 1985, the National prevalence rate of leprosy has reduced from 5.7 per 10,000 in 1983 to 1.7 per 10,000 in 1992. The Research Unit in NLCC was established in 1950, where cultivation of Mycobacterium leprae using mouse foot-pad technique is done. This technique is used for assessment of efficacy of chemotherapeutic agents in leprosy. Research activites are also done in collaboration with the Institute for Medical Research in Kuala Lumpur such as isolation of Mycobacterium leprae antigen using T cell clones and phenolic glycolipid antigen.
    Matched MeSH terms: Leprostatic Agents/therapeutic use
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links